Jifa Y. Zhang

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

Dual-target carbonic anhydrase inhibitors in cancer therapy: progress, challenges, and opportunities.

Dual-target carbonic anhydrase inhibitors in cancer therapy: progress, challenges, and opportunities.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Published: July 02, 2026

IDH-mutant adult-type diffuse gliomas: a clinicopathological analysis of 1 301 cases

IDH-mutant adult-type diffuse gliomas: a clinicopathological analysis of 1 301 cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: June 07, 2026

Pin1 in cancer: Signaling mechanisms, structural basis and advances in inhibitor development.

Pin1 in cancer: Signaling mechanisms, structural basis and advances in inhibitor development.

Journal: European journal of medicinal chemistry
Published: June 02, 2026

Medicinal chemistry advances of TAAR1 agonists: SAR, structural innovation, and mechanistic insights.

Medicinal chemistry advances of TAAR1 agonists: SAR, structural innovation, and mechanistic insights.

Journal: European journal of medicinal chemistry
Published: April 19, 2026

Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system.

Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system.

Journal: Frontiers in immunology
Published: April 13, 2026

Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors.

Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors.

Journal: Journal of medicinal chemistry
Published: February 24, 2026

ATI-1 mediated disruption of the VCP-UFL1-Beclin1 axis thwarts autophagy initiation to trigger metabolic catastrophe in autophagy-addicted cancers.

ATI-1 mediated disruption of the VCP-UFL1-Beclin1 axis thwarts autophagy initiation to trigger metabolic catastrophe in autophagy-addicted cancers.

Journal: Bioorganic chemistry
Published: February 02, 2026

Advances in Small Molecule Research Targeting Monoacylglycerol Lipase in Drug Discovery.

Advances in Small Molecule Research Targeting Monoacylglycerol Lipase in Drug Discovery.

Journal: Medicinal research reviews
Published: January 21, 2026

ALDH1A inhibitors: Research advances in cancer therapeutics.

ALDH1A inhibitors: Research advances in cancer therapeutics.

Journal: European journal of medicinal chemistry
Published: September 12, 2025

Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma.

Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma.

Journal: Cell
Published: March 29, 2025

Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery.

Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery.

Journal: Drug discovery today
Published: February 13, 2025

Correction to "Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy".

Correction to "Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy".

Journal: Journal of medicinal chemistry
Published: January 31, 2025
Showing 1-12 of 100

Last Updated: 09/26/2026